Essential and categorical agreement rates by applying CLSI and EUCAST breakpoints against S. aureus and CoNS.
收藏数据链接：
官方服务：
资源简介：
CLSI, Clinical Laboratory Standards Institute. Breakpoints: Vancomicyn: S. aureus S≤2, I 4-8, R≥16, CoNS S≤4, I 8-16, R≥32; Teicoplanin: S≤8, I 16, R≥32; Linezolid: S≤4, R≥8.EUCAST, European Committee on Antimicrobial Susceptibility Testing. Breakpoints: Vancomicyn: S. aureus S≤2, R>2, CoNS S≤4, R>4; Teicoplanin: S. aureus S≤2, R>2, CoNS S≤4, R>4; Linezolid: S≤4, R>4.
创建时间：
2015-12-02
